Dr. Brian J. Czerniecki, M.D., Ph.D.
Claim this profileMoffitt Cancer Center
Studies Breast Cancer
Studies Minimal Residual Disease
6 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
HER2 positive
2Minimal Residual Disease
HER2 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Brian J. Czerniecki, M.D., Ph.D. is currently running
HER2 DC1 Vaccine + Chemotherapy
for Breast Cancer
The purpose of the study is to find out if an investigational drug called Dendritic Cell (DC1) vaccine added to standard neoadjuvant (given before main treatment) therapy can help people with HER2 (human epidermal growth factor receptor 2) positive breast cancer.
Recruiting3 awards Phase 27 criteria
Dendritic Cell Vaccine
for Breast Cancer
The purpose of the study is to find out if an investigational vaccine called Dendritic Cell (DC) vaccine given together with standard of care chemotherapy drugs can help people with Triple Negative and HR low positive breast cancer.
Recruiting1 award Phase 15 criteria
More about Brian J. Czerniecki, M.D., Ph.D.
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Brian J. Czerniecki, M.D., Ph.D. has experience with
- HER2-primed Dendritic Cells
- HER3-primed Dendritic Cells
- DC1 Vaccine
- WOKVAC Vaccine
- EnVisio Navigation System
- EnVisio SmartClip
Breakdown of trials Brian J. Czerniecki, M.D., Ph.D. has run
Breast Cancer
Minimal Residual Disease
Breast cancer
Residual Disease
Leptomeningeal Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian J. Czerniecki, M.D., Ph.D. specialize in?
Brian J. Czerniecki, M.D., Ph.D. focuses on Breast Cancer and Minimal Residual Disease. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Brian J. Czerniecki, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Brian J. Czerniecki, M.D., Ph.D. is currently recruiting for 4 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Brian J. Czerniecki, M.D., Ph.D. has studied deeply?
Yes, Brian J. Czerniecki, M.D., Ph.D. has studied treatments such as HER2-primed Dendritic cells, HER3-primed Dendritic cells, DC1 Vaccine.
What is the best way to schedule an appointment with Brian J. Czerniecki, M.D., Ph.D.?
Apply for one of the trials that Brian J. Czerniecki, M.D., Ph.D. is conducting.
What is the office address of Brian J. Czerniecki, M.D., Ph.D.?
The office of Brian J. Czerniecki, M.D., Ph.D. is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.